Transforming growth factor beta-1 and beta-2 and type II receptor functional regulation of ALVA-101 human prostate cancer cells

Metabolism: Clinical and Experimental

Volumn 48, Issue 9, 1999, Pages 1075-1081

  Meikle, A Wayne ^a   Swope, Richard E ^a   Yin, Diana Y ^a   Fullmer, Dan ^a   Loop, Steven M ^a   Murray, Darrell K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RECEPTOR BINDING;

EID: 0032871273     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90118-X     Document Type: Article

References (47)

1. Centrella M, Horowitz MC, Wozney JM, et al: Transforming growth factor-beta gene family members and bone. Endocr Rev 15:27-39, 1994
2. Iseki S, Osumi-Yamashita N, Miyazono K, et al: Localization of transforming growth factor-beta type I and type II receptors in mouse development. Exp Cell Res 219:339-347, 1995
3. Thesleff I, Vaahtokari A, Partanen AM: Regulation of organogenesis. Common molecular mechanisms regulating the development of teeth and other organs. Int J Dev Biol 39:35-50. 1995
4. Wall NA, Hogan BL: TGF-beta related genes in development. Curr Opin Genet Dev 4:517-522, 1994
5. Harris SE, Harris MA, Mahy P, et al: Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate 24:204-211, 1994
6. Battegay EJ: Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73:333-346, 1995
7. Yoshikawa H, Takaoka K: Bone remodeling and its regulators. Nippon Rinsho 52:2262-2267, 1994
8. Adzick NS, Lorenz HP: Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 220:10-18, 1994
9. Gressner AM: Activation of proteoglycan synthesis in injured liver - A brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem 32:225-237, 1994
10. Morton DM, Barrack ER: Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix. Cancer Res 55:2596-2602, 1995
11. Timme TL, Truong LD, Slawin KM, et al: Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth. Microsc Res Tech 30:333-341, 1995
12. Cox DA: Transforming growth factor-beta 3. Cell Biol Int 19:357-371, 1995
13. Sunderkotter C, Steinbrink K, Goebeler M, et al: Macrophages and angiogenesis. J Leukoc Biol 55:410-422, 1994
14. Floege J, Eng E, Young BA, et al: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 39:47-54, 1993
15. Sunderkotter C, Goebeler M, Schulze Osthoff K, et al: Macrophage-derived angiogenesis factors. Pharmacol Ther 51:195-216, 1991
16. Merz VW, Arnold AM, Studer UE: Differential expression of transforming growth factor-beta 1 and beta 3 as well as c-fos mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer. World J Urol 12:96-98, 1994
17. Eastham JA, Truong LD, Rogers E, et al: Transforming growth factor-beta 1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest 73:628-635, 1995
18. Glynne Jones E, Harper ME, Goddard L, et al: Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 25:210-218, 1994
19. Kyprianou N, Bains AK, Jacobs SC: Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death. Prostate 25:66-75, 1994
20. Kyprianou N, Tu H, Jacobs SC: Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 27:668-675, 1996
21. Furaya Y, Isaacs JT: Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology 133:2660-2666, 1993
22. Furuya Y, Lin XS, Walsh JC, et al: Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction. Endocrinology 136:1898-1906, 1995
23. Franzen P, Ichijo H, Miyazono K: Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp Cell Res 207:1-7, 1993
24. Lokeshwar BL, Block NL: Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta. Cancer Res 52:5821-5825, 1992
25. Kim IY, Ahn HJ, Zelner DJ, et al: Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells. Cancer Res 56:44-48, 1996
26. Santen RJ, Mowszowicz I, Portois MC, et al: Androgen dependence of the Dunning R3327G cell line in monolayer culture. Prostate 11:377-387, 1987
27. Henttu P, Vihko P: Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53:1051-1058, 1993
28. Hara Y: Analysis of anchorage independent growth of human prostate cancer cell line LNCaP. Nippon Hinyokika Gakkai Zasshi 83:1429-1435, 1992
29. Goldstein D, O'Leary M, Mitchen J, et al Effects of Interferon beta ser and transforming growth factor beta on prostatic cell lines. J Urol 146:1173-1177, 1991
30. Kim IY, Zelner DJ, Sensibar JA, et al: Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone. Exp Cell Res 222:103-110, 1996
31. Liu X, Wiley HS, Meikle AW. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/ TGF-alpha receptor. J Clin Endocrinol Metab 77:1472-1478, 1993
32. Mosmann T: Rapid colorimetric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
33. Kooistra A, van den Eijnden-van Raaij AJ, Klaij IA, et al: Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta. Br J Cancer 72:427-434, 1995
34. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 106:1659-1665, 1988
35. Frolik CA, Wakefield LM, Smith DM, et al. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J Biol Chem 259:10995-11000, 1984
36. Wade TP, Kasid A, Stein CA, et al: Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture. J Surg Res 53:195-198, 1992
37. Scatchard G: The attraction of protein for small molecules and ions. Ann NY Acad Sci 51:660-672, 1949
38. Gilman M: Preparation and analysis of RNA, in Ausubel FM, Brent R, Kingston RE, et al (eds): Current Protocols in Molecular Biology. New York, NY, Wiley, p 4.1.4
39. Lin HY, Wang XF, Ng-Eaton E, et al: Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase [published erratum appears in Cell 70:1068, 1992. Cell 68.775-785, 1992
40. Watt R, Ware JL, Levy J, et al: Transforming growth factor beta 1 regulation of human prostate cancer. Endocr Soc 74:1046A, 1992 (abstr)
41. Steiner MS, Barrack ER. Transforming growth factor-B 1 overproduction in prostate cancer: Effects on growth in vivo and in vitro. Mol Endocrinol 6:15-25, 1992
42. Story MT, Baeten LA, Molter MA, et al: Influence of androgen and transforming growth factor beta on basic fibroblast growth factor levels in human prostate-derived fibroblast cell cultures. J Urol 143:241A, 1990 (abstr)
43. Wilding G, Zugneier G, Knabbe C, et al: Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79-87, 1989
44. Muir GH, Butta A. Shearer RJ. et al: Induction of transforming growth factor beta in hormonally treated human prostate cancer. Br J Cancer 69:130-134, 1994
45. Story M, Hopp K, Meier D, et al: Influence of transforming growth factor beta 1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 22:183-197, 1993
46. Sokoloff MH, Tso CL, Kaboo R, et al: In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines. Cancer 77:1862-1872, 1996
47. Oh Y, Muller HL, Ng L, et al: Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 270:13589-13592, 1995